Identification of an in vivo orally active dual-binding protein-protein interaction inhibitor targeting TNFα through combined in silico/in vitro/in vivo screening.
作者:
主题词
投药, 口服(Administration, Oral);别构调节(Allosteric Regulation);动物(Animals);消炎药(Anti-Inflammatory Agents);细胞系, 肿瘤(Cell Line, Tumor);药物评价, 临床前(Drug Evaluation, Preclinical);女(雌)性(Female);HEK293细胞(HEK293 Cells);高通量筛选分析(High-Throughput Screening Assays);人类(Humans);小鼠(Mice);小鼠, 近交BALB C(Mice, Inbred BALB C);蛋白质结合(Protein Binding);受体, 肿瘤坏死因子(Receptors, Tumor Necrosis Factor);小分子化合物库(Small Molecule Libraries);肿瘤坏死因子α(Tumor Necrosis Factor-alpha)
DOI
10.1038/s41598-017-03427-z
PMID
28611375
发布时间
2019-01-13
- 浏览5

Scientific reports
3424页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文